Liminatus Pharma LIMN
NASDAQ LIMN
$3.73 -0.18 (-4.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Other Non-Current Liabilities (2025 - 2026)

Updated

Liminatus Pharma (LIMN) posted Other Non-Current Liabilities of $62,667 for Q2 2026, down 68.7% from $200,450 a year earlier but up 87.5% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends

At the end of FY2025, Liminatus Pharma's Other Non-Current Liabilities came in at $29,244.

  • Quarterly Other Non-Current Liabilities has run from a low of $29,244 in Q4 2025 to a high of $200,450 in Q2 2025 over five years.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $33,422 (Q1 2026), $29,244 (Q4 2025) and $123,579 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Liminatus Pharma 4.18 Mn 4.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 62,667.00
Mar 31, 2026 33,422.00
Dec 31, 2025 29,244.00
Sep 30, 2025 123,579.00
Jun 30, 2025 200,450.00
API Access

Liminatus Pharma Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LIMN&period=max&api_key=YOUR_API_KEY